Journalist Hunt

JournalistsPricingBlogs

Max Gelman - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Max Gelman's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Max Gelman

Max Gelman

Verified

Senior Editor, Endpoints News

New York

Beats

Primary beats

United StatesHealthEnvironmentMetro New York

Secondary beats

HousingInnovation In BusinessEthicsReal EconomyHumorFaithPublic Health InitiativesNet-ZeroInvestigative FeaturesGeneral NewsDoctorsHealthcare SystemsEnvironmental Issues

Biography

Reporting on pharma and biotech, @endpts. Baseball fan, Northwestern alum. Email: max@endpointsnews.com

Doesn’t Cover

Not a fan of the blanket embargo.

Journalist Type

-

Seniority Positions

Senior

Industries

Medium Formats

-

Content

Total articles 1896

  • Sanofi to pay $125M upfront for two immunology drugs from little-known biotech

    By Max Gelman Verified · Endpoints News

    Apr. 17, 2025

  • Eli Lilly reports first Phase 3 data for oral GLP-1, posting a win in diabetes

    By Max Gelman Verified · Endpoints News

    Apr. 17, 2025

As seen in

Invesbrain,Daily Northwestern,Endpoints News,Mlb,New York Daily News,St. Louis Post-Dispatch,The Post Game

Company Info

Endpoints News

Lawrence, Kansas, United States

+1 785-813-1733

Founded: 2014